LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES-36-MONTH DATA FROM THE RELIANCE REGISTRY

被引：0

作者：

Kuemmerle-Deschner, J. B. ^{[1
]}

Kortus-Goetze, B. ^{[2
]}

Oommen, P. ^{[3
]}

Janda, A. ^{[4
]}

Rech, J. ^{[5
,6
]}

Schuetz, C. ^{[7
]}

Kallinich, T. ^{[8
]}

Weller-Heinemann, F. ^{[9
]}

Horneff, G. ^{[10
]}

Foeldvari, I. ^{[11
]}

Meier, F. ^{[12
,13
]}

Borte, M. ^{[14
]}

Krickau, T. ^{[15
]}

Weber-Arden, J. ^{[16
]}

Blank, N. ^{[17
]}

机构：

[1] Univ Hosp Tuebingen, Div Pediat Rheumatol, Dept Pediat, Tubingen, Germany

[2] Univ Marburg, Div Nephrol, Marburg, Germany

[3] Heinrich Heine Univ Dusseldorf, Div Pediat Rheumatol, Clin Pediat Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[4] Ulm Univ, Dept Pediat & Adolescent Med, Med Ctr, Ulm, Germany

[5] Friedrich Alexander Univ FAU Erlangen Nurnberg, Erlangen, Germany

[6] Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany

[7] Tech Univ Dresden, Med Fak Carl Gustav Carus, Pediat, Dresden, Germany

[8] Charite Univ Med Berlin, Div Pulmonol Immunol & Crit Care Med, Dept Pediat, Berlin, Germany

[9] Klinikum Bremen Mitte, Prof Hess Kinderklinik, Bremen, Germany

[10] Asklepios Clin Sankt Augustin, St Augustin, Germany

[11] Ctr Pediat & Adolescence Rheumatol Hamburg, Hamburg, Germany

[12] Goethe Univ, Univ Hosp Frankfurt, Frankfurt, Germany

[13] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany

[14] Hosp St Georg gGmbH Leipzig, ImmunoDeficiency Ctr Leipzig IDCL, Leipzig, Germany

[15] Friedrich Alexander Univ Erlangen Nurnberg FAU, Pediat, Erlangen, Germany

[16] Novartis Pharma GmbH, IHD, Nurnberg, Germany

[17] Univ Hosp Heidelberg, Rheumatol, Heidelberg, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.4753

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0220

引用

页码：346 / 347

页数：2

共 50 条

[1] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY
Kuemmerle-Deschner, J. B.
Kortus-Goetze, B.
Oommen, P.
Janda, A.
Rech, J.
Kallinich, T.
Weller-Heinemann, F.
Horneff, G.
Foeldvari, I.
Schuetz, C.
Borte, M.
Braner, A.
Weber-Arden, J.
Blank, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 50 - 51
[2] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-4-YEARS DATA FROM THE RELIANCE REGISTRY
Kuemmerle-Deschner, J. B.
Kortus-Goetze, B.
Schuetz, C.
Oommen, P.
Janda, A.
Rech, J.
Weller-Heinemann, F.
Kallinich, T.
Pankow, A.
Horneff, G.
Foeldvari, I.
Wasiliew, P.
Borte, M.
Fiene, M.
Meier, F.
Krickau, T.
Andreica, I.
Weber-Arden, J.
Blank, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 167 - 167
[3] Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
Walker, Ulrich A.
Tilson, Hugh H.
Hawkins, Philip N.
van der Poll, Tom
Noviello, Stephanie
Levy, Jeremy
Vritzali, Eleni
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
[J]. RMD OPEN, 2021, 7 (02):
[4] LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME
Kuemmerle-Deschner, J. B.
Blank, Norbert
Borte, Michael
Foeldvari, Ivan
Horneff, Gerd
Oommen, Prasad
Schuetz, Catharina
Weller-Heinemann, Frank
Weber-Arden, Julia
Kallinich, Tilmann
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 156 - 157
[5] 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry
Kuemmerle-Deschner, Jasmin B.
Kortus-Goetze, Birgit
Oommen, Prasad T.
Janda, Ales
Rech, Juergen
Schuetz, Catharina
Kallinich, Tilmann
Weller-Heinemann, Frank
Horneff, Gerd
Foeldvari, Ivan
Meier, Florian
Borte, Michael
Krickau, Tobias
Weber-Arden, Julia
Blank, Norbert
[J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1613 - 1614
[6] LONG-TERM SAFETY OF CANAKINUMAB IN AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES-48-MONTH DATA FROM THE RELIANCE REGISTRY
Kuemmerle-Deschner, J. B.
Henes, J.
Kortus-Goetze, B.
Oommen, P.
Pankow, A.
Kallinich, T.
Krickau, T.
Schuetz, C.
Horneff, G.
Foeldvari, I.
Rech, J.
Weller-Heinemann, F.
Janda, A.
Hufnagel, M.
Meier, F.
Dressler, F.
Borte, M.
Andreica, I.
Wasiliew, P.
Fiene, M.
Windschall, D.
Weber-Arden, J.
Blank, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1153 - 1153
[7] Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry
Kuemmerle-Deschner, Jasmin
Kortus-Goetze, Birgit
Oommen, Prasad T.
Janda, Ales
Rech, Juergen
Kallinich, Tilmann
Weller-Heinemann, Frank
Horneff, Gerd
Foeldvari, Ivan
Schuetz, Catharina
Borte, Michael
Braner, Axel
Weber-Arden, Julia
Blank, Norbert
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 381 - 382
[8] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN FAMILIAL MEDITERRANEAN FEVER (FMF)-36-MONTH DATA FROM THE RELIANCE REGISTRY
Henes, J.
Blank, N.
Krickau, T.
Pankow, A.
Foeldvari, I.
Dressler, F.
Horneff, G.
Kallinich, T.
Oommen, P.
Meier, F.
Weller-Heinemann, F.
Kortus-Goetze, B.
Hufnagel, M.
Rech, J.
Andreica, I.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1160 - 1161
[9] EVALUATION OF LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB THERAPY IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM BETA-CONFIDENT REGISTRY
Kuemmerle-Deschner, J.
Hoffman, H.
Hawkins, P.
van der Poll, T.
Walker, U.
Speziale, A.
Tilson, H.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 850 - 850
[10] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
Kuemmerle-Deschner J.
Hoffman H.
Hawkins P.N.
van der Poll T.
Walker U.A.
Speziale A.
Tilson H.H.
[J]. Pediatric Rheumatology, 13 (Suppl 1)

← 1 2 3 4 5 →